The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 04, 2018

Filed:

Mar. 13, 2017
Applicant:

University of Wyoming, Laramie, WY (US);

Inventor:

Jared Bushman, Laramie, WY (US);

Assignee:

UNIVERSITY OF WYOMING, Laramie, WY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 38/13 (2006.01); A61K 31/436 (2006.01); A61K 31/573 (2006.01); C07K 16/18 (2006.01); A61K 47/10 (2017.01); A61K 9/51 (2006.01); A61L 27/36 (2006.01); A61L 27/48 (2006.01); A61L 27/54 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 9/5153 (2013.01); A61K 31/436 (2013.01); A61K 31/573 (2013.01); A61K 38/13 (2013.01); A61K 39/39541 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61L 27/3604 (2013.01); A61L 27/3675 (2013.01); A61L 27/48 (2013.01); A61L 27/54 (2013.01); C07K 16/18 (2013.01); C07K 16/2809 (2013.01); C07K 16/2866 (2013.01); C07K 16/2893 (2013.01); A61L 2430/32 (2013.01); C07K 2317/24 (2013.01);
Abstract

Embodiments described herein relate to restorative solutions for segmental peripheral nerve (PN) defects using allografted PNs for stimulating PN repair. More specifically, embodiments described herein provide for localized immunosuppression (LIS) surrounding PN allografts as an alternative to systemically suppressing a patient's entire immune system. Methods include localized release of immunosuppressive (ISV) agents are contemplated in one embodiment. Methods also include localized application of immunosuppressive (ISV) regulatory T-cells (Tregs) in other embodiments. Hydrogel carrier materials for delivery of ISV agents and are also described herein.


Find Patent Forward Citations

Loading…